相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics
Massimo Bogliolo et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2015)
Addiction to MTH1 protein results in intense expression in human breast cancer tissue as measured by liquid chromatography-isotope-dilution tandem mass spectrometry
Erdem Coskun et al.
DNA REPAIR (2015)
Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer
Kevin M. Foote et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair
Nuria Segui et al.
GASTROENTEROLOGY (2015)
Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma The Lung Cancer Mutation Consortium Experience
Lynette M. Sholl et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2
Megan Carter et al.
NATURE COMMUNICATIONS (2015)
MTH1 expression is required for effective transformation by oncogenic HRAS
Maria G. Giribaldi et al.
ONCOTARGET (2015)
Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors
Alexander G. Goglia et al.
MOLECULAR CANCER THERAPEUTICS (2015)
MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways
A. Patel et al.
ONCOGENE (2015)
Therapeutic opportunities within the DNA damage response
Laurence H. Pearl et al.
NATURE REVIEWS CANCER (2015)
Cancer phenotypic lethality, exemplified by the non-essential MTH1 enzyme being required for cancer survival
T. Helleday
ANNALS OF ONCOLOGY (2014)
ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses
Rozenn Josse et al.
CANCER RESEARCH (2014)
A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
Sergey Alekseev et al.
CHEMISTRY & BIOLOGY (2014)
CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
Leena Chaudhuri et al.
HAEMATOLOGICA (2014)
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
Kilian V. M. Huber et al.
NATURE (2014)
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Helge Gad et al.
NATURE (2014)
Unravelling the genomic targets of small molecules using high-throughput sequencing
Raphael Rodriguez et al.
NATURE REVIEWS GENETICS (2014)
A High Through-Put Screen for Small Molecules Modulating MCM2 Phosphorylation Identifies Ryuvidine as an Inducer of the DNA Damage Response
Jennifer FitzGerald et al.
PLOS ONE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Sources of DNA Double-Strand Breaks and Models of Recombinational DNA Repair
Anuja Mehta et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Oxidative stress and cancer: An overview
Venus Sosa et al.
AGEING RESEARCH REVIEWS (2013)
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
Cynthia X. Ma et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status
Catherine J. Huntoon et al.
CANCER RESEARCH (2013)
Identification of Early Replicating Fragile Sites that Contribute to Genome Instability
Jacqueline H. Barlow et al.
CELL (2013)
ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA
Luis Ignacio Toledo et al.
CELL (2013)
Transcription-Associated Genome Instability
Helene Gaillard et al.
CHEMICAL REVIEWS (2013)
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Kahlin Cheung-Ong et al.
CHEMISTRY & BIOLOGY (2013)
Replication stress links structural and numerical cancer chromosomal instability
Rebecca A. Burrell et al.
NATURE (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Modulation of oxidative stress as an anticancer strategy
Chiara Gorrini et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress
R. M. Jones et al.
ONCOGENE (2013)
Systems Biology Approach Identifies the Kinase Csnk1a1 as a Regulator of the DNA Damage Response in Embryonic Stem Cells
Jordi Carreras Puigvert et al.
SCIENCE SIGNALING (2013)
Senataxin Associates with Replication Forks to Protect Fork Integrity across RNA-Polymerase-II-Transcribed Genes
Amaya Alzu et al.
CELL (2012)
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions
Anitha Suram et al.
EMBO JOURNAL (2012)
Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates COMPARISON WITH MTH1 AND MTH2
Yasumitsu Takagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Y-family DNA polymerases and their role in tolerance of cellular DNA damage
Julian E. Sale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
E. Fokas et al.
CELL DEATH & DISEASE (2012)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
Kurtis D. Davies et al.
CANCER BIOLOGY & THERAPY (2011)
Nucleotide Deficiency Promotes Genomic Instability in Early Stages of Cancer Development
Assaf C. Bester et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells
Andreas Hoeglund et al.
CLINICAL CANCER RESEARCH (2011)
The xeroderma pigmentosum pathway: Decision tree analysis of DNA quality
Hanspeter Naegeli et al.
DNA REPAIR (2011)
Crystal structure of human MTH1 and the 8-oxo-dGMP product complex
Linda M. Svensson et al.
FEBS LETTERS (2011)
Targeting ATR and Chk1 kinases for cancer treatment: A new model for new (and old) drugs
Luis I. Toledo et al.
MOLECULAR ONCOLOGY (2011)
Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Philip M. Reaper et al.
NATURE CHEMICAL BIOLOGY (2011)
Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
Matilde Murga et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
A cell-based screen identifies ATR inhibitors with synthetic lethal properties for cancer-associated mutations
Luis I. Toledo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Oxidative stress and oxidative damage in chemical carcinogenesis
James E. Klaunig et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
Cynthia X. Ma et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer
Rachel Abbotts et al.
CANCER TREATMENT REVIEWS (2010)
Methylated DNA Causes a Physical Block to Replication Forks Independently of Damage Signalling, O6-Methylguanine or DNA Single-Strand Breaks and Results in DNA Damage
Petra Groth et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair
Eva Petermann et al.
MOLECULAR CELL (2010)
Mechanisms of dealing with DNA damage in terminally differentiated cells
P. Fortini et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Chk1 promotes replication fork progression by controlling replication initiation
Eva Petermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Y-family DNA polymerases in mammalian cells
Caixia Guo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Eukaryotic DNA replication control: Lock and load, then fire
Dirk Remus et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability
Renee D. Paulsen et al.
MOLECULAR CELL (2009)
Highly Transcribed RNA Polymerase II Genes Are Impediments to Replication Fork Progression in Saccharomyces cerevisiae
Anna Azvolinsky et al.
MOLECULAR CELL (2009)
Role of mismatch repair and MGMT in response to anticancer therapies
Ida Casorelli et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies
Sonya D. Zabludoff et al.
MOLECULAR CANCER THERAPEUTICS (2008)
ATR: an essential regulator of genome integrity
Karlene A. Cimprich et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control
Deborah Wilsker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study
P. K. Tsantoulis et al.
ONCOGENE (2008)
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity
Petra Willems et al.
GENES CHROMOSOMES & CANCER (2008)
High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathways
Bin Zhang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Transcription-associated recombination is dependent on replication in mammalian cells
Ponnari Gottipati et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Regulation of DNA double-strand break repair pathway choice
Meena Shrivastav et al.
CELL RESEARCH (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase
Nadine K. Kolas et al.
SCIENCE (2007)
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Weidong Wang
NATURE REVIEWS GENETICS (2007)
Understanding ribonucleotide reductase inactivation by gemcitabine
Nuno M. F. S. A. Cerqueira et al.
CHEMISTRY-A EUROPEAN JOURNAL (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
D Chirnomas et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Is base excision repair a tumor suppressor mechanism?
JB Sweasy et al.
CELL CYCLE (2006)
Targeted modulation of MGMT: Clinical implications
LL Liu et al.
CLINICAL CANCER RESEARCH (2006)
Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells
C Morales et al.
ONCOGENE (2005)
Recruitment of DNA methyltransferase I to DNA repair sites
O Mortusewicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients
E Speina et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6
AW Plug-DeMaggio et al.
ONCOGENE (2004)
Visualization of altered replication dynamics after DNA damage in human cells
CJ Merrick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides
JP Cai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
K Rothkamm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Defective DNA repair and increased genomic instability in artemis-deficient murine cells
S Rooney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
ATR regulates fragile site stability
AM Casper et al.
CELL (2002)
Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells
C Lundin et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Deficiency in BRCA2 leads to increase in non-conservative homologous recombination
F Larminat et al.
ONCOGENE (2002)
The connection between transcription and genomic instability
A Aguilera
EMBO JOURNAL (2002)
Genome maintenance mechanisms for preventing cancer
JHJ Hoeijmakers
NATURE (2001)
DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells
C Arnaudeau et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Xenopus ATR is a replication-dependent chromatin-binding protein required for the DMA replication checkpoint
M Hekmat-Nejad et al.
CURRENT BIOLOGY (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
